Ting-Chi Lu is a Nephrology physician. OpenAlex indexes 9 publications with 561 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
321 W Ben White Blvd
Ste 205
Austin, TX 787047035
Telephone
512-451-5800Provider last certified this registry record 4 Apr 2023.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bayer Healthcare Pharmaceuticals Inc.Program year20256 payments
- Travere Therapeutics, Inc.Program year20256 payments
- Amgen Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
62.6%Beta blocker12%Carvedilol62%Metoprolol Succinate21%Metoprolol Tartrate17%Part D<11 patientsLoop diuretic10.3%Furosemide77%Torsemide23%Part D≥31 patients+ 10 more classes in this area
Metabolism & gastrointestinal
23.3%SGLT2 inhibitor13.1%Jardiance51%Farxiga49%Part D≥15 patientsVitamin D3 Analog4.3%Calcitriol100%Part D≥14 patients+ 3 more classes in this area
Other
5.3%Phosphate Binder4.2%Sevelamer Carbonate100%Part D≥19 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia1.2%Auryxia100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Reduction of Stat3 Activity Attenuates HIV-Induced Kidney Injury
Journal of the American Society of Nephrology
2009 - HIV-1 Nef Disrupts the Podocyte Actin Cytoskeleton by Interacting with Diaphanous Interacting Protein
Journal of Biological Chemistry
2008
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”